Clinical trial
Open Label Randomized Study to Assess Safety and Efficacy of Azithromycin Versus Meglumine Antimoniate to Treat Cutaneous Leishmaniasis
NCT00682656 is registered in ClinicalTrials.gov with Ana Rabello as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Open Label Randomized Study to Assess Safety and Efficacy of Azithromycin Versus Meglumine Antimoniate to Treat Cutaneous Leishmaniasis
- Lead sponsor
- Ana Rabello
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- June 30, 2008
- Completion date
- September 30, 2012
- Enrollment
- 48 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cutaneous leishmaniasis